Stay updated on Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.

Latest updates to the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRemoved the 'Interstitial lung disease 2' entry and the Genetic and Rare Diseases Information Center resource from the page. These items are auxiliary and do not affect the presentation of the trial details.SummaryDifference0.1%

- Check21 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0, indicating a maintenance/UI update without changes to study details.SummaryDifference0.0%

- Check28 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.2 has been added; the prior 'Notice Because of a lapse in government funding...' message (v3.4.1) has been removed.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a government funding/status notice about potential delays and the NIH Clinical Center’s operations. The release version was updated to Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.2%

- Check71 days agoChange DetectedShow glossary feature added and page revision updated to v3.4.0, introducing a 'Last Update Submitted that Met QC Criteria' label and a 'No FEAR Act Data' notice; the previous 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' entries were removed.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.